|国家科技期刊平台
首页|期刊导航|新医学|拷贝数变异在卵巢癌中的研究进展

拷贝数变异在卵巢癌中的研究进展OACSTPCD

Research progress in copy number variation in ovarian cancer

中文摘要英文摘要

遗传变异是导致癌症发生和发展的重要因素之一.拷贝数变异是遗传多样性的重要来源,在结构上表现为基因的扩增或缺失,与肿瘤的发生和发展有关.采用高通量测序和基因芯片技术可以检测拷贝数的变异情况,提供相关的肿瘤分子特征、预后和治疗相关的信息,有利于临床上对患者进行更准确的诊断和治疗决策.卵巢癌在女性生殖系统疾病中的病死率极高,了解其发病机制对提高卵巢癌患者的生存率至关重要.目前拷贝数变异在卵巢癌中的具体作用和机制仍然不清楚,文章就现有的研究结果对与卵巢癌相关的拷贝数变异进行综述,以期为卵巢癌的预防、诊断及治疗等方面提供新的思路和方法.

Genetic variation is one of the important factors leading to the incidence and development of cancer.Copy number variation is an important source of genetic diversity,which can be expressed as gene amplification or deletion in structure,and is related to the occurrence and development of different tumors.High-throughput sequencing and gene chip technology can be adopted to detect the variation of copy number,and provide relevant information about tumor molecular characteristics,prognosis and treatment,which is conducive to more accurate diagnosis and treatment decisions for patients in clinical practice.Ovarian cancer is one of the female reproductive system diseases with the highest mortality rate.Understanding its pathogenesis is of significance for improving the survival rate of ovarian cancer.At present,the specific role and mechanism of copy number variation in ovarian cancer are still unclear.In this article,relevant copy number variation in ovarian cancer was reviewed based on the existing research results,aiming to provide novel ideas and methods for the prevention,diagnosis and treatment of ovarian cancer.

孙梦娜;徐盈;任晨璐;闫雨帆;陈志浩;杨红

空军军医大学第一附属医院妇产科,陕西 西安 710032

拷贝数变异卵巢肿瘤高通量测序基因芯片遗传变异

Copy number variationOvarian cancerHigh-throughput sequencingGene chipGenetic variation

《新医学》 2024 (009)

738-744 / 7

国家自然科学基金(82172993);陕西省创新平台(2023PT-07)

10.3969/j.issn.0253-9802.2024.09.009

评论